您当前的位置：
首页 >
文章列表页 >
A study of 30-year trends in incidence and mortality risks of breast cancer among young women in China
Article | 更新时间：2026-02-09

    • A study of 30-year trends in incidence and mortality risks of breast cancer among young women in China

    • “This paper introduces its research progress in the field of breast cancer. Experts analyzed the incidence and death data of breast cancer among Chinese women aged 15-39 years from 1992 to 2021. They found that the incidence risk increased and the death risk decreased, providing a new direction for disease prevention and control research.”
    • China Oncology   Vol. 35, Issue 12, Pages: 1091-1098(2025)

    • DOI：10.19401/j.cnki.1007-3639.2025.12.001    

      CLC： R737.9

    • Received：26 June 2025，

      Revised：2025-09-23，

      Published：30 December 2025

    移动端阅览

  • DING Lingling, ZHENG Ying, MO Miao. A study of 30-year trends in incidence and mortality risks of breast cancer among young women in China[J]. China Oncology, 2025, 35(12): 1091-1098. DOI： 10.19401/j.cnki.1007-3639.2025.12.001.

  •  
  •  

0

Views

25

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

A single-center retrospective study on the feasibility of omitting axillary surgery in patients with HR+/HER- early-stage breast cancer
NOD1 promotes breast cancer progression through remodeling tumor-associated macrophage in tumor immune microenvironment
Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)
Progress and prospects of CENPA-driven chromosomal instability in breast cancer: mechanisms, prognostic implications, and therapeutic perspectives
Impact of miR-193a-3p on migration and invasion of breast cancer stem cells through targeting TRIM14

Related Author

DU Xueying
BI Zhao
SUN Xiao
LIU Yanbing
ZHANG Zhaopeng
WANG Yongsheng
LI Dongjing
MA Wei

Related Institution

Department of Breast Surgery, Affiliated Cancer Hospital of Shandong First Medical University
Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine
Institutes of Biomedical Sciences, Fudan University
Cancer Institute, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
0